Skip to main content
Tobias Walbert, MD, Neurology, Detroit, MI, Henry Ford Hospital

TobiasWalbertMD

Neurology Detroit, MI

Neurooncology, Hospice and Palliative Medicine

Associate Professor, Neurology, Wayne State University SOM

Dr. Walbert is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Walbert's full profile

Already have an account?

Education & Training

  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterFellowship, Neuro-Oncology, 2008 - 2010
  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Neurology, 2005 - 2008
  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterInternship, Internal Medicine, 2004 - 2005
  • Other
    OtherClass of 2000

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • MI State Medical License
    MI State Medical License 2009 - 2026
  • OH State Medical License
    OH State Medical License 2004 - 2008
  • American Board of Internal Medicine Hospice and Palliative Medicine
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Looking to Fill Glioblastoma Multiforme Treatment Gap with Berubicin Drug Product
    CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Looking to Fill Glioblastoma Multiforme Treatment Gap with Berubicin Drug ProductAugust 30th, 2022
  • Henry Ford Health Researchers Launch Clinical Trial Studying Therapy Aimed at Causing Brain Cancer Cells to Self-Destruct
    Henry Ford Health Researchers Launch Clinical Trial Studying Therapy Aimed at Causing Brain Cancer Cells to Self-DestructJune 10th, 2023

Hospital Affiliations